ALA-1000, Long-acting Injectable of Buprenorphine for treating Chronic Pain and Addiction

Category:Finished Dosage > Antipyretic and Analgesic Preparations
Product Name:ALA-1000, Long-acting Injectable of Buprenorphine for treating Chronic Pain and Addiction
CAS No.:NA
Standard:In-house Standards
Price(USD):Negotiable
Company:Alar Pharmaceuticals Inc.

Basic Info
  • Grade: pharmaceutical grade, injection grade

    Factory Location: Taiwan

    Main Sales Markets: North America,Western Europe,Asia

  • Sample Provided: no

    Payment Terms: L/C

    ALA-1000 is designed as a subcutaneous injection to be administered once every month or three months, delivering Buprenorphine to treat chronic pain or opioid use disorder (OUD). The proposed buprenorphine systemic exposure resulting from the ALA-1000 injection remains effective over three months per administration and benefits patients by reducing the burden of daily administration, improving patient compliance, and diminishing the concerns of misuse, abuse and accidental pediatric exposure.

Send your message to this supplier
  • From:
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service